scispace - formally typeset
G

Gholamhossein Hassanshahi

Researcher at Rafsanjan University of Medical Sciences

Publications -  192
Citations -  3084

Gholamhossein Hassanshahi is an academic researcher from Rafsanjan University of Medical Sciences. The author has contributed to research in topics: Chemokine & Immune system. The author has an hindex of 27, co-authored 185 publications receiving 2510 citations. Previous affiliations of Gholamhossein Hassanshahi include University of Bristol & Kerman Medical University.

Papers
More filters
Journal ArticleDOI

The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis

Reza Vazirinejad, +4 more
- 01 Jan 2014 - 
TL;DR: The aim of this review is to address recent findings regarding the relationship between CXCL10 and MS.
Journal ArticleDOI

Students’ perceptions of the academic learning environment in seven medical sciences courses based on DREEM

Hamid Bakhshialiabad, +2 more
- 23 Mar 2015 - 
TL;DR: The results showed that it is essential for faculty members and course managers to make more efforts toward observing principles of instructional designs, to create an appropriate educational environment, and to reduce deficits in order to provide a better learning environment with more facilities and supportive systems for the students.
Journal ArticleDOI

Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients.

Mohammad Kazemi Arababadi, +4 more
- 01 Jan 2010 - 
TL;DR: This study investigated the association between polymorphisms in intron 8 and exon 9 of the vitamin D receptor (VDR) with OBI and found that vitamin D3 and its known receptor appear to be involved in antiviral immune responses.
Journal Article

Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients

Mohammad Kazemi Arababadi, +3 more
- 01 Mar 2010 - 
TL;DR: The higher level of IL-10 production may suppress the functioning of the immune system against HBV in OBI patients, and the elevated IL-17A serum level also indicates a long period of infection in the patients observed.
Journal ArticleDOI

CCL2/CCR2 signaling pathway in glioblastoma multiforme.

Alireza Vakilian, +5 more
- 01 Feb 2017 - 
TL;DR: Potential application of this chemokine/receptor interaction axis for the expansion of future anti-glioma therapies as well is discussed.